Nutritional aspects regarding lung cancer chemoprevention
- PMID: 17318947
Nutritional aspects regarding lung cancer chemoprevention
Abstract
Lung cancer is still one of the major causes of cancer-related deaths and its mortality figures argue powerfully for new approaches to control this leading cancer threat. Chemoprevention can be defined as the use of specific agents to reverse, or prevent premalignancy from progressing to invasive cancer. The use of foods and dietary supplements present a safe chemopreventive strategy. Data for this review were identified by searches of PubMed and references from relevant articles. Articles were identified by use of the search terms "lung cancer", "chemoprevention", "carcinogenesis", and "retinoids". Only papers published in English were included. Trials in lung cancer chemoprevention have so far produced either neutral or harmful primary endpoint results, whether in the primary, secondary, or tertiary settings. Lung cancer was not prevented by beta-carotene, alpha-tocopherol, retinol, retinyl palmitate, N-acetylcysteine, or isotretinoin in smokers. Ongoing trials may help define new avenues for chemoprevention. The concept of chemoprevention in lung cancer is still in its infancy, but in the future it may have a significant impact on the incidence and mortality of lung cancer. In addition to epidemiologic studies, basic science research to detect mechanisms and evaluate the chemopreventive potential of food components is necessary. The overwhelming evidence of a major role of nutrition in carcinogenesis, the many leads that nutritional intervention may reduce cancer incidence, and the growth and increasing sophistication of clinical trials networks point to a very promising future for nutritional intervention trials leading to substantial public benefit.
Similar articles
-
Lung cancer chemoprevention: an integrated approach.J Clin Oncol. 2001 Sep 15;19(18 Suppl):74S-82S. J Clin Oncol. 2001. PMID: 11560978 Review.
-
Progress in lung cancer chemoprevention.Cancer Control. 2003 Jul-Aug;10(4):315-24. doi: 10.1177/107327480301000406. Cancer Control. 2003. PMID: 12915810 Review.
-
Chemoprevention of lung cancer.Curr Opin Pulm Med. 2004 Jul;10(4):279-83. doi: 10.1097/01.mcp.0000129754.97392.d5. Curr Opin Pulm Med. 2004. PMID: 15220752 Review.
-
Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.Eur J Cancer Prev. 2007 Jun;16(3):184-91. doi: 10.1097/01.cej.0000215612.98132.18. Eur J Cancer Prev. 2007. PMID: 17415088 Review.
-
Molecularly targeted approaches to the chemoprevention of lung cancer.Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4249s-4253s. doi: 10.1158/1078-0432.CCR-040019. Clin Cancer Res. 2004. PMID: 15217968 Review.
Cited by
-
Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer.J Clin Trials. 2014 Sep;4(4):180. doi: 10.4172/2167-0870.1000180. J Clin Trials. 2014. PMID: 26101725 Free PMC article.
-
Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice.Cancer Prev Res (Phila). 2008 Sep;1(4):285-97. doi: 10.1158/1940-6207.CAPR-08-0012. Cancer Prev Res (Phila). 2008. PMID: 19138972 Free PMC article.
-
N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adduct.Free Radic Biol Med. 2008 Mar 15;44(6):1069-74. doi: 10.1016/j.freeradbiomed.2007.12.016. Epub 2007 Dec 23. Free Radic Biol Med. 2008. PMID: 18206665 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical